ContextVision AB presents Q3 2017 Financial report
ContextVision establishes unique platform for future growth within digital pathology STOCKHOLM - October 26, 2017 - ContextVision, a medical technology company specializing in image analysis and artificial intelligence, has heavily invested in developing state-of-the-art competence within artificial intelligence and the development of a first product within digital pathology that will make the diagnosis of prostate cancer both quicker and more accurate. The product will be ready for market by the end of 2018, as previously announced. "The product development is going very well and